Foundry Partners, LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Foundry Partners, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 23, 2021	SELL	$62.15 - $90.32 $593,594 - $862,646	-9,551 Closed	0 $0
Q1 2021 May 12, 2021	SELL	$61.35 - $90.47 $269,203 - $396,982	-4,388 Reduced 31.48%	9,551 $633,000
Q4 2020 Feb 04, 2021	BUY	$43.82 - $85.37 $610,806 - $1.19 Million	13,939 New	13,939 $1.07 Million

304

95.8M

523K

493K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $1.56B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Foundry Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Foundry Partners, LLC with notifications on news.